In a report released today, Emily Field from Barclays maintained a Buy rating on Genmab A/S (0MGB – Research Report), with a price target of ...

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK890.00.

For Q4 2024, the Harding Loevner International Developed Markets Equity composite fell 8.4% (gross) behind the 7.4% decline ...